US2008194023A1PendingUtilityA1
Generating vascular smooth muscle cells in vitro from ES cells
Assignee: TECHNION RES & DEV FOUNDATIONPriority: Apr 16, 2002Filed: Dec 4, 2007Published: Aug 14, 2008
Est. expiryApr 16, 2022(expired)· nominal 20-yr term from priority
A61K 45/00C12N 2501/115A61K 35/12C12N 5/0606C12N 2506/02
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A simplified and inexpensive method for the in-vitro identification, isolation and culture of human vasculogenic progenitor cells is provided. The method and the progenitor cells provided herein can be used for in-vitro vascular engineering, treatment of congenital and acquired vascular and hematological abnormalities, for evaluation and development of drugs affecting vasculo- and angiogenic processes, and for further investigation into tissue differentiation and development.
Claims
exact text as granted — not AI-modified1 . A method of preparing somatic cells from a population of vasculogenic progenitor cells, the method comprising:
(a) obtaining a population of vasculogenic progenitor cells; and (b) culturing the population of vasculogenic progenitor cells in the presence of at least one growth factor suitable for inducing somatic cell differentiation, thereby preparing the somatic cells.
2 . A method of preparing endothelial cells from vascular tissue, the method comprising:
(a) subjecting the vascular tissue to conditions designed for dissociating cells from the vascular tissue, thereby obtaining a mixed population of dissociated cells; and (b) isolating cells smaller than 50 μm from said mixed population of cells, said cells smaller than 50 μm being endothelial cells.
3 . The method of claim 2 , wherein said cells smaller than 50 μm are isolated by filtration, morphometry and/or densitometry.
4 . The method of claim 3 , wherein said isolation by filtration is effected via a filter having a pore size smaller than 50 μm.
5 . The method of claim 2 , wherein said vascular tissue is human vascular tissue.
6 . A method of preparing epithelial cells from vascular tissue, the method comprising:
(a) subjecting the vascular tissue to conditions designed for dissociating cells from the vascular tissue, thereby obtaining a mixed population of dissociated cells; and (b) isolating cells larger than 50 μm from said mixed population of cells, said cells larger than 50 μm being epithelial cells.
7 . The method of claim 6 , wherein said cells larger than 50 μm are isolated by filtration, morphometry and/or densitometry.
8 . The method of claim 7 , wherein said isolation by filtration is effected via a filter having a pore size smaller than 50 μm.
9 . The method of claim 6 , wherein said vascular tissue is human vascular tissue.
10 . A method of generating epithelial cells from vasculogenic progenitor cells, comprising culturing the vasculogenic progenitor cells in a differentiating medium including a serum volume concentration lower than 5% for a time period sufficient to induce differentiation of the vasculogenic progenitor cells into endothelial cells.
11 . The method of claim 10 , wherein said vasculogenic progenitor cells are derived from ES cells.
12 . The method of claim 11 , wherein said ES cells are human ES cells.
13 . A method of enhancing differentiation, maturation and/or functionality of vasculogenic cells, comprising exposing the vasculogenic cells to a shear force of at least 1 dyne/cm 2 for a time period sufficient to enhance differentiation, maturation and/or functionality of the vasculogenic cells.
14 . The method of claim 13 , wherein said vasculogenic cells are vascular smooth muscle cells or endothelial cells derived from ES cells.Join the waitlist — get patent alerts
Track US2008194023A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.